{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:05:26Z","timestamp":1790384726539,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,3,24]],"date-time":"2017-03-24T00:00:00Z","timestamp":1490313600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Pacific Edge Ltd."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s12325-017-0518-7","type":"journal-article","created":{"date-parts":[[2017,3,24]],"date-time":"2017-03-24T09:22:44Z","timestamp":1490347364000},"page":"1087-1096","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Clinical Utility of Cxbladder for the Diagnosis of Urothelial Carcinoma"],"prefix":"10.1007","volume":"34","author":[{"given":"David","family":"Darling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carthika","family":"Luxmanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"O\u2019Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Lough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Suttie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,24]]},"reference":[{"key":"518_CR1","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1097\/01.gim.0000227935.26763.c6","volume":"8","author":"SD Grosse","year":"2006","unstructured":"Grosse SD, Khoury MJ. What is the clinical utility of genetic testing? Genet Med. 2006;8:448\u201350.","journal-title":"Genet Med"},{"key":"518_CR2","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1158\/1078-0432.CCR-13-2961","volume":"20","author":"DR Parkinson","year":"2014","unstructured":"Parkinson DR, McCormack RT, Keating SM, et al. Evidence of clinical utility: an unmet need in molecular diagnostics for patients with cancer. Clin Cancer Res. 2014;20:1428\u201344.","journal-title":"Clin Cancer Res"},{"key":"518_CR3","first-page":"750","volume":"20","author":"JW Peabody","year":"2014","unstructured":"Peabody JW, Shimkhada R, Tong KB, et al. New thinking on clinical utility: hard lessons for molecular diagnostics. Am J Manag Care. 2014;20:750\u20136.","journal-title":"Am J Manag Care"},{"issue":"6 Suppl","key":"518_CR4","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1016\/j.juro.2012.09.078","volume":"188","author":"R Davis","year":"2012","unstructured":"Davis R, Jones JS, Barocas DA, et al. Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline. J Urol. 2012;188(6 Suppl):2473\u201381.","journal-title":"J Urol"},{"key":"518_CR5","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1046\/j.1464-410X.1996.01975.x","volume":"78","author":"S Sultana","year":"1996","unstructured":"Sultana S, Goodman C, Bryne D, Baxby K. Microscopic haematuria: urological investigation using a standard protocol. Br J Urol. 1996;78:691\u20138.","journal-title":"Br J Urol"},{"key":"518_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1442-2042.2001.00235.x","volume":"8","author":"K Sugimura","year":"2001","unstructured":"Sugimura K, Ikemoto S-I, Kawashima H, Nishisaka N, Kishimoto T. Microscopic hematuria as a screening marker for urinary tract malignancies. Int J Urol. 2001;8:1\u20135.","journal-title":"Int J Urol"},{"key":"518_CR7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1308\/003588408X242006","volume":"90","author":"S Viswanath","year":"2008","unstructured":"Viswanath S, Zelhof B, Ho E, Sethia K, Mills R. Is routine urine cytology useful in the haematuria clinic? Ann R Coll Surg Engl. 2008;90:153\u20135.","journal-title":"Ann R Coll Surg Engl"},{"key":"518_CR8","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.juro.2016.06.049","volume":"196","author":"SS Chang","year":"2016","unstructured":"Chang SS, Boorjian SA, Chou R, et al. Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline. J Urol. 2016;196:1021\u20139.","journal-title":"J Urol"},{"key":"518_CR9","doi-asserted-by":"publisher","first-page":"488","DOI":"10.7326\/M15-1496","volume":"164","author":"M Nielsen","year":"2016","unstructured":"Nielsen M, Qaseem A, High Value Care Task Force of the American College of Physicians. Hematuria as a marker of occult urinary tract cancer: advice for high-value care from the American College of Physicians. Ann Intern Med. 2016;164:488\u201397.","journal-title":"Ann Intern Med"},{"key":"518_CR10","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/ijcp.12075","volume":"67","author":"TRL Griffiths","year":"2013","unstructured":"Griffiths TRL, on behalf of Action on Bladder Cancer. Current perspectives in bladder cancer management. Int J Clin Pract. 2013;67:435\u201348.","journal-title":"Int J Clin Pract"},{"key":"518_CR11","doi-asserted-by":"crossref","unstructured":"Schmitz-Dr\u00e4ger, Droller M, Lokeshwar VB, et al. Molecular markers for bladder cancer screening, early diagnosis and surveillance: the WHO\/ICUD consensus. Urol Int. 2015;94:1\u201324.","DOI":"10.1159\/000369357"},{"key":"518_CR12","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1046\/j.1464-4096.2001.01899.x","volume":"89","author":"DM Burke","year":"2002","unstructured":"Burke DM, Shackley DC, O\u2019Reilly PH. The community-based morbidity of flexible cystoscopy. BJU Int. 2002;89:347\u20139.","journal-title":"BJU Int"},{"key":"518_CR13","first-page":"474","volume":"6","author":"K Stav","year":"2004","unstructured":"Stav K, Leibovici D, Goren E, et al. Adverse effects of cystoscopy and its impact on patients\u2019 quality of life and sexual performance. Isr Med Assoc J. 2004;6:474.","journal-title":"Isr Med Assoc J"},{"key":"518_CR14","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.juro.2014.07.015","volume":"193","author":"HW Herr","year":"2015","unstructured":"Herr HW. The risk of urinary tract infection after flexible cystoscopy in bladder tumor patients who did not receive prophylactic antibiotics. J Urol. 2015;193:548\u201351.","journal-title":"J Urol"},{"key":"518_CR15","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/iju.13032","volume":"23","author":"M Jinzaki","year":"2016","unstructured":"Jinzaki M, Kikuchi E, Akita H, Sugiura H, Shinmoto H, Oya M. Role of computed tomography urography in the clinical evaluation of upper tract urothelial carcinoma. Int J Urol. 2016;23:284\u201398.","journal-title":"Int J Urol"},{"key":"518_CR16","doi-asserted-by":"crossref","unstructured":"Blackwell RH, Kirshenbaum EJ, Zapf MAC, et al. Incidence of adverse contrast reaction following nonintravenous urinary tract imaging. Eur Urol 2016 [Epub ahead of print].","DOI":"10.1016\/j.euf.2016.01.009"},{"key":"518_CR17","first-page":"8792984","volume":"2016","author":"S Bhatt","year":"2016","unstructured":"Bhatt S, Rajpal N, Rathi V, et al. Contrast induced nephropathy with intravenous iodinated contrast media in routine diagnostic imaging: an initial experience in a Tertiary Care Hospital. Radiol Res Pract. 2016;2016:8792984.","journal-title":"Radiol Res Pract"},{"key":"518_CR18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12894-015-0018-5","volume":"15","author":"L Kavalieris","year":"2015","unstructured":"Kavalieris L, O\u2019Sullivan PJ, Suttie JM, et al. A segregation index combining phenotypic (clinical characteristics) and genotypic (gene expression) biomarkers from a urine sample to Triage out patients presenting with hematuria who have a low probability of urothelial carcinoma. BMC Urol. 2015;15:23.","journal-title":"BMC Urol"},{"key":"518_CR19","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.juro.2012.05.003","volume":"188","author":"P O\u2019Sullivan","year":"2012","unstructured":"O\u2019Sullivan P, Sharples K, Dalphin M, et al. A multigene urine test for the detection and stratification of bladder cancer in patients presenting with hematuria. J Urol. 2012;188:741\u2013747.","journal-title":"J Urol"},{"key":"518_CR20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12874-015-0036-8","volume":"15","author":"A Breen","year":"2015","unstructured":"Breen A, Kasabov N, Kamat AM, et al. A holistic comparative analysis of diagnostic tests for urothelial carcinoma: a study of Cxbladder Detect, UroVysion\u00ae FISH, NMP22\u00ae and cytology based on imputation of multiple datasets. BMC Med Res Methodol. 2015;15:45.","journal-title":"BMC Med Res Methodol"},{"key":"518_CR21","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1001\/jama.1990.03440180081037","volume":"263","author":"JM Sutton","year":"1990","unstructured":"Sutton JM. Evaluation of hematuria in adults. JAMA. 1990;263:2475\u201380.","journal-title":"JAMA"},{"key":"518_CR22","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/S0022-5347(05)67916-5","volume":"163","author":"MH Khadra","year":"2000","unstructured":"Khadra MH, Pickard RS, Charlton M, Powell PH, Neal DE. A prospective analysis of 1,930 patients with hematuria to evaluate clinical practice. J Urol. 2000;163:524\u20137.","journal-title":"J Urol"},{"issue":"4S","key":"518_CR23","doi-asserted-by":"publisher","first-page":"e495","DOI":"10.1016\/j.juro.2011.02.907","volume":"185","author":"P Davidson","year":"2011","unstructured":"Davidson P. Re-design of a haematuria clinic: assessment of 2346 haematuria patients. J Urol. 2011;185(4S):e495.","journal-title":"J Urol"},{"key":"518_CR24","doi-asserted-by":"publisher","first-page":"e584","DOI":"10.3399\/bjgp14X681409","volume":"64","author":"SJ Price","year":"2014","unstructured":"Price SJ, Shephard EA, Stapley SA, Barraclough K, Hamilton WT. Non-visible versus visible haematuria and bladder cancer risk: a study of electronic records in primary care. Br J Gen Pract. 2014;64:e584\u20139.","journal-title":"Br J Gen Pract"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-017-0518-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-017-0518-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-017-0518-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T20:15:17Z","timestamp":1692735317000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-017-0518-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,24]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["518"],"URL":"https:\/\/doi.org\/10.1007\/s12325-017-0518-7","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,24]]},"assertion":[{"value":"22 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2017","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}